Modelling patient trajectories in emergency department simulations using retrospective patient cohorts
Abstract
Computer simulations of emergency departments (EDs) are tools that can support managing and optimising ED operations. A core component of ED simulation models is patient trajectories, defined as the series of activities patients undergo in the ED from arrival to discharge. The combined duration of these activities, and waiting times between them, determines a patient's length of stay (LOS). Patient trajectories are often calibrated and validated solely based on the estimated acuity of patients assigned upon arrival. However, acuity is a prospective patient indicator that inconsistently reflects patients' actual urgency and resource usage as seen retrospectively upon discharge. Here, we propose a data-driven ED simulation model in which patient trajectories are modelled based on both acuity and retrospective patient indicators. We show that including retrospective patient indicators recovers the observed LOS distributions more accurately than when using acuity alone. We also demonstrate how the use of retrospective patient indicators leads to more plausible estimates of the impact of increased stress in the ED on patients' LOS. Our work exemplifies how we can better utilise ED data to make the development and evaluation of ED simulation models more accurate and robust, enabling them to provide more reliable and useful operational insights.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.